Voyager Technologies stock jumps again on ISS drug-discovery deal, Wedbush call — what to watch next
Voyager Technologies shares closed up 7.4% at $37.09 Friday after announcing a contract with Space LiinTech for a microgravity drug research payload to the ISS. Wedbush initiated coverage with an Outperform rating and $46 target. Liberty Street Advisors disclosed a $17.8 million stake as of Dec. 31. Investors await updates at February conference appearances.